Welltower stock heads toward October 26 results

Published on 10/06/2026 at 15:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Welltower stock closed at USD 224.16 on October 5, 2026, down 1.56 percent. Q2 revenue reached USD 3.54 billion before the October 26 results date.

Flatlay mit Aktienzertifikat, ISIN-Karte US95040Q1040 und Stethoskop für Welltower Inc — Welltower Inc. (US95040Q1040) Anlageobjekt symbolisiert durch Aktienzertifikat, ISIN-Karte und medizinische Utensilien im Flatlay, Illustration mit AI erstellt.

Welltower Inc. (ISIN US95040Q1040) closed at USD 224.16 on the NYSE on October 5, 2026, down 1.56 percent from the prior close. The healthcare real estate investment trust will release third quarter 2026 results after the market close on October 26, according to MarketScreener on September 23, 2026.

October 26 sets the next test

The upcoming report will show whether Welltower can extend the operating gains reported for Q2 2026. The company has scheduled a conference call and webcast for October 27, 2026, at 9:00 a.m. ET, giving investors a second checkpoint after the release.

Welltower's Q2 revenue rose 39.1 percent year over year to USD 3.54 billion, compared with USD 2.52 billion in the prior-year quarter, while net profit was USD 240.29 million, according to Markets Insider on October 1, 2026.

Revenue growth meets an earnings test

The operating picture was mixed. Q2 EPS came in at USD 0.61, below the USD 0.66 consensus, even as revenue exceeded the USD 3.40 billion estimate; fiscal 2026 EPS guidance stands at USD 6.360-6.440, according to MarketBeat on September 18, 2026. That combination puts the October report under a clear test: revenue expansion must continue while per-share earnings close the gap to expectations.

Analysts keep targets above the stock

The analyst backdrop remains constructive. MarketBeat reported on September 18, 2026, that 14 of 17 covering brokerages rated Welltower Buy and three rated it Hold, producing a Moderate Buy consensus and an average 12-month target of USD 252.5556. That average target lies 12.67 percent above the October 5 closing price.

BMO Capital analyst Juan C. Sanabria reiterated a Buy rating and set a USD 265.00 target on October 1, 2026, as reported by Markets Insider. The counterweight is valuation sensitivity: a Q2 EPS miss means the next release must support the premium implied by those targets.

Welltower stock stays below its yearly high

Welltower stock closed at USD 224.16 on October 5, 2026, with a 52-week range of USD 163.75 to USD 255.20. Its market capitalization was USD 161.5 billion, and volume reached 2,446,966 shares on the same date.